Revoche e sospensioni, ritiri di lotti, farmaci carenti, note di sicurezza, rimborsabilità e nuovi medicinali — ogni giorno, automaticamente. Ultimo aggiornamento: 01/10/2026 08:15.
n. EU/1/26/2058 · Susvimo is indicated in adult patients for the treatment of neovascular (wet) age related macular degeneration… · Roche Registration GmbH · ranibizumab · ATC S01LA04
n. EU/1/26/2061 · LYROKAUL is indicated in adults with primary hypercholesterolaemia (heterozygous familial (HeFH) and non-famil… · LIB Therapeutics B.V. · Lerodalcibep · ATC C10AX19
n. EU/1/23/1751 · autorizzato il 15/09/2023 · Yesafili is indicated for adults for the treatment of
• neovascular (wet) age-related macular degeneration (… · Biosimilar Collaborations Ireland Limited · aflibercept · ATC S01LA05
n. EU/1/23/1758 · autorizzato il 15/09/2023 · Non-small cell lung cancer (NSCLC)
Tevimbra, in combination with platinum-containing chemotherapy as neoadj… · BeOne Medicines Ireland Limited · tislelizumab · ATC L01FF09
n. EU/1/20/1498 · autorizzato il 09/12/2020 · Trixeo Aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic ob… · AstraZeneca AB · Formoterol / glycopyrronium bromide / budesonide · ATC R03AL11
n. EU/1/21/1588 · autorizzato il 12/11/2021 · Rivaroxaban Viatris co-administered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel or ticl… · Viatris Limited · rivaroxaban · ATC B01AF01
n. EU/1/21/1604 · autorizzato il 06/01/2022 · Riltrava Aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic … · AstraZeneca AB · formoterol / glycopyrronium bromide / budesonide · ATC R03AL11
n. EU/1/01/189 · autorizzato il 03/08/2001 · Replagal is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry… · Takeda Pharmaceuticals International AG Ireland Branch · Agalsidase alfa · ATC A16AB03
n. EU/1/19/1404 · autorizzato il 16/12/2019 · Rheumatoid arthritis
RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthriti… · AbbVie Deutschland GmbH & Co. KG · upadacitinib · ATC L04AF03
n. EU/1/25/1909 · autorizzato il 04/04/2025 · Pavblu is indicated for adults for the treatment of
• neovascular (wet) age-related macular degeneration (AM… · Amgen Technology (Ireland) UC · Aflibercept · ATC S01LA05
n. EU/1/24/1863 · autorizzato il 25/09/2024 · Adult Crohn’s disease
Otulfi is indicated for the treatment of adult patients with moderately to severely act… · Fresenius Kabi Deutschland GmbH · ustekinumab · ATC L04AC05
n. EU/1/24/1865 · autorizzato il 13/11/2024 · Opuviz is indicated for adults for the treatment of
• neovascular (wet) age related macular degeneration (AMD… · Samsung Bioepis NL B.V. · Aflibercept · ATC S01LA05
n. EU/1/18/1277 · autorizzato il 19/04/2018 · MYLOTARG is indicated for combination therapy with daunorubicin (DNR) and cytarabine (AraC) for the treatment … · Pfizer Europe MA EEIG · gemtuzumab ozogamicin · ATC L01FX02
n. EU/1/22/1649 · autorizzato il 03/06/2022 · Lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicula… · Roche Registration GmbH · mosunetuzumab · ATC L01FX25
n. EU/1/23/1755 · autorizzato il 15/09/2023 · Litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and… · Pfizer Europe MA EEIG · ritlecitinib · ATC L01EJ
n. EU/1/19/1356 · autorizzato il 02/04/2019 · Rheumatoid arthritis
Idacio in combination with methotrexate, is indicated for:
the treatment of moderate… · Fresenius Kabi Deutschland GmbH · adalimumab · ATC L04AB04
n. EU/1/24/1802 · autorizzato il 17/05/2024 · Paroxysmal nocturnal haemoglobinuria
FABHALTA is indicated as monotherapy in the treatment of adult patients … · Novartis Europharm Limited · iptacopan · ATC L04AJ08
n. EU/1/12/797 · autorizzato il 22/11/2012 · Eylea 40 mg/mL :
Eylea is indicated for adults for the treatment of
• neovascular (wet) age-related macul… · Bayer AG · aflibercept · ATC S01LA05
n. EU/1/25/1963 · autorizzato il 14/08/2025 · Eiyzey is indicated for adults for the treatment of
• neovascular (wet) age-related macular degeneration (AMD… · Zakłady Farmaceutyczne POLPHARMA S.A. · aflibercept · ATC S01LA05
n. EU/1/15/1047 · autorizzato il 23/11/2015 · BLINCYTO is indicated as monotherapy for the treatment of adults with CD19 positive relapsed or refractory B c… · Amgen Europe B.V. · blinatumomab · ATC L01FX07
n. EU/1/24/1888 · autorizzato il 13/01/2025 · Ahzantive is indicated for adults for the treatment of:
• neovascular (wet) age-related macular degeneration … · Formycon AG · Aflibercept · ATC S01LA05
fine presunta 31/10/2026 · Problemi produttivi · equivalente: Sì · 500 MG COMPRESSE RIVESTITE CON FILM - 5 COMPRESSE IN BLISTER PVC/PVDC/AL · AIC 039686136 · TEVA ITALIA S.R.L. · LEVOFLOXACINA · ATC J01MA12
fine presunta 31/10/2026 · Elevata richiesta · equivalente: Sì · 2G/0,25G POLVERE PER SOLUZIONE PER INFUSIONE- 10 FLACONCINI IN VETRO DA 30 ML · AIC 050401025 · TILLOMED ITALIA SRL · PIPERACILLINA SODICA/TAZOBACTAM SODICO · ATC J01CR05
fine presunta 31/01/2027 · Problemi produttivi · equivalente: No · 5 G-POLVERE E GEL PER GEL -USO CUTANEO-POLVERE:FLACONCINO (VETRO) GEL: FLACONE (VETRO)-POLV: 5 G GEL: 50 G - 1 FLACONCINO+1 FLACONE · AIC 042539027 · MEDIWOUND GERMANY GMBH · BROMELINA · ATC D03BA03
Problemi produttivi · equivalente: No · SOSPENSIONE INIETTABILE IN SIRINGA PRERIEMPITA- 1 SIRINGA DA 0,5 ML SENZA AGO · AIC 003671106 · ASTRO-PHARMA VERTRIEB UND HANDEL VON PHARMAZEUTISCHEN PRODUKTEN GMBH · ANATOSSINA TETANICA/ANATOSSINA DIFTERICA · ATC J07AM51
problemi produttivi: carenza sul canale retail; sul canale ospedaliero si garantiscono le forniture a seguito di gare aggiudicate · equivalente: Sì · 0,52 MG COMPRESSE A RILASCIO PROLUNGATO- 10 COMPRESSE IN BLISTER OPA-AL-PVC/AL · AIC 043042047 · SANDOZ A/S · PRAMIPEXOLO · ATC N04BC05
problemi produttivi: carenza sul canale retail; sul canale ospedaliero si garantiscono le forniture a seguito di gare aggiudicate · equivalente: Sì · 100 MG COMPRESSE- 28 COMPRESSE IN BLISTER PVC/AL · AIC 042365039 · SANDOZ S.P.A. · CILOSTAZOLO · ATC B01AC23
n. EU/1/24/1844 · autorizzato il 22/08/2024 · Adult Crohn’s Disease
Steqeyma is indicated for the treatment of adult patients with moderately to severely a… · Celltrion Healthcare Hungary Kft. · ustekinumab · ATC L04AC05
n. EU/1/08/461 · autorizzato il 11/07/2008 · Firazyr is indicated for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adol… · Takeda Pharmaceuticals International AG Ireland Branch · icatibant · ATC B06AC02
Lekoskop